STAT

MARCH 7, 2024

weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. The drug is also sold as a diabetes treatment under the name Ozempic. In a Phase 1 trial, participants experienced an average of 13.1% billion in sales last year.

Diabetes 328

Diabetes 328

STAT

DECEMBER 6, 2023

In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. The news about anti-obesity drugs keeps getting better. That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering.

Diabetes 280

Diabetes Drug Pricing 280

STAT

APRIL 4, 2024

Meanwhile, we are proud to present our latest list of interesting items for you to peruse. A drugmaker in China has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval to sell it there, in a potential challenge to Novo expansion plans in the country , Reuters writes.

Diabetes 235

Diabetes Biosimilars 235

pharmaphorum

AUGUST 24, 2021

million in first-round financing, which it will use to scale up its clinical tool that it says helps people “prevent, manage and reverse type 2 diabetes.” It also sets competitive challenges to improve behaviours, provides a forum to interact with other people with diabetes, and access to a personal coach.

Diabetes 126

Diabetes 126

Express Pharma

AUGUST 28, 2023

Queen’s University Belfast has designed a new 3D printed bandage which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs). These scaffolds can release both a bulk and sustained release of antibiotic loaded molecules to treat diabetic ulcers.

Diabetes 94

Diabetes Dosage Compounding Hospitals 94

Pharmaceutical Technology

OCTOBER 7, 2022

Provention Bio and Sanofi US have signed a co-promotion agreement to launch the former’s lead investigational drug candidate, teplizumab for the delay in the onset of clinical type 1 diabetes (T1D). The US Food and Drug Administration (FDA) is presently reviewing teplizumab for the delay of clinical T1D in people who are at risk.

Diabetes 119

Diabetes 119

STAT

FEBRUARY 8, 2024

On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.  

Drug Pricing 277

Drug Pricing Diabetes 277

ALiEM - Pharm Pearls

OCTOBER 20, 2023

A 50-year-old Caucasian female with a history of hypertension, coronary artery disease, and insulin-dependent diabetes mellitus presents to the emergency department with a complaint of painful sores on the top of her left foot. It may be equally common in patients without diabetes, hence was renamed without the term “diabeticorum”.

Diabetes 161

Diabetes 161

STAT

JUNE 23, 2023

The full   results,  published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference. The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year.

Diabetes 253

Diabetes Drug Development 253

STAT

DECEMBER 12, 2023

So join us as we hoist the ever-present cup of stimulation — our choice today is gingerbread — and attack the fast-growing to-do list. People who discontinue Wegovy and Novo Nordisk’s diabetes medication Ozempic have also regained weight, raising concerns among U.S. We trust you have your own hectic agendas.

Diabetes 230

Diabetes 230

Pharmaceutical Technology

APRIL 16, 2024

NNC0519-0130 is commercialized by Novo Nordisk, with a leading Phase II program in Type 2 Diabetes.

Diabetes 75

Diabetes 75

pharmaphorum

JULY 12, 2021

Bayer’s big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA approval, although it could face stiff competition in the market. . The post Bayer’s finerenone gets FDA nod for diabetic kidney disease appeared first on.

Diabetes 98

Diabetes 98

STAT

JUNE 26, 2023

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Diabetes 245

Diabetes Drug Development 245

PharmaShots

APRIL 10, 2023

Shots: With an incurable nature and hefty medication costs, diabetes mellitus remains a global health concern and the seventh leading cause of death across the world. Diabetes, aka diabetes mellitus is a condition that arises when the pancreas fails to produce enough insulin or the cells of the body do not respond to the insulin produced.

Diabetes 40

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 40

Express Pharma

APRIL 25, 2023

Novo Nordisk collaborated with United Diabetes Forum (UDF) and Harley Owners Group to orchestrate a 90-minute ride from Bandra to Worli in Mumbai. In India, an estimated 135 million people live with Obesity which is almost double the number of people living with diabetes at present.

Diabetes 55

Diabetes 55

Pharmacy Times

JUNE 26, 2023

The results of the study were presented at the 83rd Scientific Sessions of the American Diabetes Association in San Diego, California and were also published in The Lancet.

Diabetes 49

Diabetes 49

pharmaphorum

SEPTEMBER 22, 2022

Insulin has been used to manage diabetes for a century, and while many advances have been made for people with both type 1 and type 2 diabetes – many more continue to be made. Tune in below for a fascinating discussion of the cutting edge of diabetes management.

Diabetes 52

Diabetes 52

STAT

NOVEMBER 13, 2023

 But details, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented as the first major session of the American Heart Association conference. Continue to STAT+ to read the full story…

Diabetes 232

Diabetes 232

Pharma Leaders

JUNE 12, 2023

The FDA will not let Intarcia choose reviewers for the upcoming Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) meeting to consider the company’s troubled diabetes drug-device product, nor will the agency grant other requests Intarcia made last month.

Diabetes 40

Diabetes 40

Pharmaceutical Technology

MARCH 13, 2024

(Insulin icodec + Semaglutide) is a recombinant peptide and recombinant protein commercialized by Novo Nordisk, with a leading Phase III program in Type 2 Diabetes.

Diabetes 40

Diabetes 40

pharmaphorum

AUGUST 8, 2022

Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his team created that allows anyone to live the life of a type 2 diabetes patient for 24 hours. Therefore, Doyle and his team created The Life in a Day immersive experience for type 2 diabetes.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

A 64-year-old Caucasian male with a history of alcohol use disorder and tobacco use disorder presents with painless bilateral hand contractures that have been worsening for the past several months. Dupuytren’s Contracture is a clinical diagnosis that most commonly presents as painless loss of extension of the fourth and fifth phalanx.

Diabetes 152

Diabetes Clinic Management 152

Med Ed 101

SEPTEMBER 15, 2021

LT is a 67-year-old white male presenting to your ambulatory care clinic for a CMR. The post Heart Failure and Diabetes Polypharmacy Case Study appeared first on Med Ed 101. He says his wife tells him he is taking too many medications and he wants your help evaluating his current regimen.

Diabetes 40

Diabetes 40

STAT

JUNE 27, 2023

The agreement was disclosed in a consent decree in which Lilly is prevented from rejecting applicants for primary care sales positions in its diabetes and obesity business units based on age. The arrangement will last for 30 months, according to the consent decree filed in a U.S. court in Indianapolis.

Diabetes 192

Diabetes 192

LifeProNow

MARCH 7, 2024

The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin, such as individuals with diabetes treating their condition with oral medications, or those without diabetes who want to better understand how diet and exercise may impact blood sugar levels.

Diabetes 130

Diabetes 130

STAT

JANUARY 30, 2024

So join us as we hoist the ever-present cup of stimulation — our choice today is cinnamon sticky bun — and attack the fast-growing to-do list. Despite gray skies, the temperature is gradually rising and a large family of deer is parading alongside the Pharmalot campus, which our official mascots find quite provocative.

Diabetes 241

Diabetes Pharmaceutical Companies Pharmaceutical Companies 241

LifeProNow

APRIL 21, 2023

April 17, 2023 : “Bayer and its collaborator Regeneron will present new clinical data analyses for the investigational formulation aflibercept 8 mg at the Annual Meeting of The Association for Research in Vision and Ophthalmology (arvo.org) 2023 , in New Orleans, Louisiana, 23-27 April 2023.

Diabetes 100

Diabetes 100

Express Pharma

AUGUST 4, 2023

The pharma sector continues to present significant growth opportunities globally. Targeted therapies, precision medicine, and personalised treatments are gaining prominence, presenting opportunities for pharma companies to develop novel and more effective drugs. How is Novo Nordisk poised to leverage them?

Diabetes 90

Diabetes Communication 90

ALiEM - Pharm Pearls

AUGUST 18, 2023

A middle-aged man with a past medical history of hypertension and tobacco use disorder presented to the Emergency Department after evaluation by an ophthalmologist. On exam, complete CN III palsies will present with ipsilateral ptosis, “down and out” ocular deviation, and pupillary dilation.

Diabetes 130

Diabetes Communication 130

Pharmacy Times

APRIL 7, 2024

The abstracts will be presented at the American College of Cardiology Conference from April 6 to April 8, 2024, in Atlanta, Georgia.

Diabetes 49

Diabetes 49

Pharmaceutical Technology

DECEMBER 19, 2023

Lytenava is a monoclonal antibody commercialized by Outlook Therapeutics, with a leading Phase III program in Diabetic Macular Edema.

Diabetes 40

Diabetes 40

Pharmaceutical Technology

FEBRUARY 18, 2023

The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). The post Risk adjusted net present value: What is the current valuation of Novartis’s Gevokizumab? appeared first on Pharmaceutical Technology.

Diabetes 40

Diabetes Generic Medicine Biosimilars Immunity 40

Pharmaceutical Technology

FEBRUARY 24, 2023

The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). Retatrutide Overview Retatrutide (LY-3437943) is under development for the treatment of type 2 diabetes mellitus and obesity. million in FY2021.

Diabetes 45

Diabetes Immunity Immunization Pharmaceutical Companies 45

Pharmaceutical Technology

NOVEMBER 18, 2023

is a fusion protein commercialized by Celltrion, with a leading Phase III program in Diabetic Macular Edema. Aflibercept Biosimilar.

Biosimilars 40

Biosimilars Diabetes 40

Pharmaceutical Technology

NOVEMBER 18, 2023

is a fusion protein commercialized by Celltrion, with a leading Phase III program in Diabetic Macular Edema. Aflibercept Biosimilar.

Biosimilars 40

Biosimilars Diabetes 40

Pharmaceutical Technology

FEBRUARY 18, 2023

The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). The post Risk adjusted net present value: What is the current valuation of Chinook Therapeutics’s Atrasentan Hydrochloride? million the previous quarter.

Diabetes 40

Diabetes Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

NOVEMBER 18, 2023

Icovamenib is a small molecule commercialized by Biomea Fusion, with a leading Phase II program in Type 2 Diabetes.

Diabetes 40

Diabetes 40